Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this "new normal"state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.
| Original language | English (US) |
|---|---|
| Pages (from-to) | E377-E381 |
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Volume | 106 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alternative models of care
- Alternative models of care
- COVID-19
- COVID-19
- Diabetes care
- Diabetes care
- Healthcare delivery
- Healthcare delivery
- Innovation
- Innovation
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Biochemistry
- Endocrinology
- Clinical Biochemistry
- Biochemistry, medical
Fingerprint
Dive into the research topics of 'Innovations in diabetes care for a better "new normal" beyond COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS